Managers / Q1 2019 · view latest →
Worth Venture Partners, LLC
CIK 0001696778 · 2 EXECUTIVE DRIVE, SUITE 515, FORT LEE, NJ, 07024 · 2125589017
Summary
Worth Venture Partners, LLC reported $180M in U.S.-listed holdings across 204 positions for Q1 2019.
Its largest position, Square, represents 13.2% of the portfolio.
Compared with Q4 2018, the fund opened 44 new positions and exited 41.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- US DOMESTIC · 70.4% · $126M
- Common Stock · 15.2% · $27M
- Other · 6.0% · $11M
- GLOBAL · 4.3% · $8M
- ETP · 3.9% · $7M
- Other · 0.3% · $486,000
Quarter-over-Quarter Changes full breakdown →
vs Q4 2018 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| SAREPTA THERAPEUTICS INC | NEW | +6.83M | 6.83M | +$12M | $12M |
| HERBALIFE LTD | NEW | +5.00M | 5.00M | +$6M | $6M |
| RETROPHIN INC | NEW | +5.96M | 5.96M | +$6M | $6M |
| MEDICINES CO | NEW | +5.33M | 5.33M | +$4M | $4M |
| BIIBBIOGEN INC | NEW | +15.8K | 15.8K | +$4M | $4M |
| AMGNAMGEN INC | NEW | +12.5K | 12.5K | +$2M | $2M |
| ZENDESK INC | NEW | +1.50M | 1.50M | +$2M | $2M |
| BKNGBOOKING HOLDINGS ORD | NEW | +1.2K | 1.2K | +$2M | $2M |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q1 2019
| # | Issuer | Class | % Portfolio | Value ↓ | Shares |
|---|---|---|---|---|---|
| 1 | MOLINA HEALTHCARE INC | NOTE 1.125% 1/1 | 18.47% | $33M | 9.71M |
| 2 | SQUARE INC | NOTE 0.375% 3/0 | 17.24% | $31M | 9.44M |
| 3 | ADVANCED MICRO DEVICES INC | NOTE 2.125% 9/0 | 9.84% | $18M | 5.40M |
| 4 | SAREPTA THERAPEUTICS INC | DBCV 1.500%11/1 | 6.87% | $12M | 6.83M |
| 5 | CAESARS ENTMT CORP | NOTE 5.000%10/0 | 4.26% | $8M | 5.27M |
| 6 | HERBALIFE LTD | NOTE 2.000% 8/1 | 3.47% | $6M | 5.00M |
| 7 | RETROPHIN INC | NOTE 2.500% 9/1 | 3.13% | $6M | 5.96M |
| 8 | INTERCEPT PHARMACEUTICALS IN | NOTE 3.250% 7/0 | 2.76% | $5M | 4.94M |
| 9 | MEDICINES CO | NOTE 2.750% 7/1 | 2.50% | $4M | 5.33M |
| 10 | WRIGHT MED GROUP N V | NOTE 2.250%11/1 | 2.16% | $4M | 2.50M |
| 11 | BIIBBIOGEN INChistory → | COM | 2.08% | $4M | 15.8K |
| 12 | HORIZON PHARMA INVT LTD | NOTE 2.500% 3/1 | 1.91% | $3M | 3.02M |
| 13 | BMRNBIOMARIN PHARMACEUTICAL INChistory → | COM | 1.65% | $3M | 33.4K |
| 14 | AMGNAMGEN INChistory → | COM | 1.33% | $2M | 12.5K |
| 15 | SELECT SECTOR SPDR TR | SBI HEALTHCARE · SBI CONS DISCR | 1.02% | $2M | 18.4K |
| 16 | ZENDESK INC | NOTE 0.250% 3/1 | 0.93% | $2M | 1.15M |
| 17 | BKNGBOOKING HOLDINGS ORD | COM | 0.89% | $2M | 913 |
| 18 | ISHARES TR | RUSSELL 2000 ETF | 0.81% | $1M | 9.5K |
| 19 | AVID TECHNOLOGY INC | COM | 0.79% | $1M | 190.1K |
| 20 | SILICOM LTD | ORD | 0.67% | $1M | 31.3K |
| 21 | AIRGAIRGAIN ORD | COM | 0.62% | $1M | 86.1K |
| 22 | AMSCAMERICAN SUPERCONDUCTOR CORP | SHS NEW | 0.55% | $992,000 | 77.1K |
| 23 | PXLWEURPIXELWORKS INC | COM NEW | 0.50% | $904,000 | 230.6K |
| 24 | APPSDIGITAL TURBINE INC | COM NEW | 0.49% | $883,000 | 252.4K |
| 25 | QCOMQUALCOMM INC | COM | 0.49% | $876,000 | 15.4K |
| 26 | KNKNOWLES CORP | COM | 0.47% | $841,000 | 47.7K |
| 27 | REALPAGE INC | NOTE 1.500%11/1 | 0.44% | $786,000 | 509.0K |
| 28 | ALLOT COMMUNICATIONS LTD | SHS | 0.41% | $733,000 | 92.3K |
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $32M | 55 | May 14, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $14M | 53 | Feb 17, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $34M | 64 | Nov 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $65M | 42 | Aug 13, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $53M | 36 | May 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $10M | 34 | Feb 12, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $14M | 49 | Nov 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $13M | 56 | Aug 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $15M | 63 | May 13, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $185M | 130 | Feb 9, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $169M | 163 | Nov 15, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $184M | 173 | Aug 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $205M | 194 | May 15, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $169M | 183 | Feb 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $163M | 183 | Nov 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $170M | 150 | Aug 15, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $217M | 148 | May 16, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $202M | 130 | Feb 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $222M | 130 | Nov 15, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $269M | 115 | Aug 16, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $206M | 111 | May 17, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $126M | 101 | Feb 17, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $122M | 220 | Nov 16, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $204M | 220 | Aug 14, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $162M | 198 | May 15, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $204M | 178 | Feb 14, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q3 2019 | $175M | 193 | Nov 12, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q2 2019 | $181M | 197 | Aug 14, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q1 2019 | $180M | 204 | May 15, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q4 2018 | $132M | 209 | Feb 15, 2019 | 13F-HR | changes · EDGAR ↗ |
Other Included Managers
This filing reports holdings on behalf of 1 additional manager.
- DLD Asset Management, LP028-17749
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.